Noncoding RNA therapeutics—challenges and potential solutions
Therapeutic targeting of noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and
long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of …
long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of …
[HTML][HTML] Huntingtin lowering strategies for disease modification in Huntington's disease
SJ Tabrizi, R Ghosh, BR Leavitt - Neuron, 2019 - cell.com
Huntington's disease is caused by an abnormally expanded CAG repeat expansion in the
HTT gene, which confers a predominant toxic gain of function in the mutant huntingtin …
HTT gene, which confers a predominant toxic gain of function in the mutant huntingtin …
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
N Clément, JC Grieger - Molecular therapy Methods & clinical development, 2016 - cell.com
The ability to elicit robust and long-term transgene expression in vivo together with minimal
immunogenicity and little to no toxicity are only a few features that make recombinant adeno …
immunogenicity and little to no toxicity are only a few features that make recombinant adeno …
Gene therapy for the CNS using AAVs: the impact of systemic delivery by AAV9
Several attempts have been made to discover the ideal vector for gene therapy in central
nervous system (CNS). Adeno-associated viruses (AAVs) are currently the preferred vehicle …
nervous system (CNS). Adeno-associated viruses (AAVs) are currently the preferred vehicle …
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype
Reducing expression of the fetal hemoglobin (HbF) repressor BCL11A leads to a
simultaneous increase in γ-globin expression and reduction in β-globin expression. Thus …
simultaneous increase in γ-globin expression and reduction in β-globin expression. Thus …
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells
G Pavani, A Fabiano, M Laurent, F Amor… - Blood …, 2021 - ashpublications.org
Abstract β-thalassemias (β-thal) are a group of blood disorders caused by mutations in the β-
globin gene (HBB) cluster. β-globin associates with α-globin to form adult hemoglobin (HbA …
globin gene (HBB) cluster. β-globin associates with α-globin to form adult hemoglobin (HbA …
Non-coding RNAs with essential roles in neurodegenerative disorders
The importance of various classes of regulatory non-protein-coding RNA molecules
(ncRNAs) in the normal functioning of the CNS is becoming increasingly evident. ncRNAs …
(ncRNAs) in the normal functioning of the CNS is becoming increasingly evident. ncRNAs …
The next generation of rodent eradications: innovative technologies and tools to improve species specificity and increase their feasibility on islands
Rodents remain one of the most widespread and damaging invasive alien species on
islands globally. The current toolbox for insular rodent eradications is reliant on the …
islands globally. The current toolbox for insular rodent eradications is reliant on the …
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice
R Prakasam, A Bonadiman, R Andreotti… - Nature …, 2023 - nature.com
Spinobulbar muscular atrophy (SBMA) is caused by CAG expansions in the androgen
receptor gene. Androgen binding to polyQ-expanded androgen receptor triggers SBMA …
receptor gene. Androgen binding to polyQ-expanded androgen receptor triggers SBMA …
Recombinant AAV as a platform for translating the therapeutic potential of RNA interference
RNA interference has become a ubiquitous biological tool, and is being harnessed for
therapeutic purposes as well. Therapeutic posttranscriptional gene silencing takes …
therapeutic purposes as well. Therapeutic posttranscriptional gene silencing takes …